MedTrace Logo

Use of Acthar in Rheumatoid Arthritis (RA) Related Flares

NCT02541955 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-02-10

No results posted yet for this study

Summary

This is a Rheumatoid Arthritis (RA) study. The purpose of this research study is to determine in RA flare, whether musculoskeletal ultrasound (MSUS) inflammatory scores and/or disease activity scores improve with Acthar treatment.

Conditions

  • Rheumatoid Arthritis (RA)

Interventions

DRUG

Acthar

Injections will be self administered

Sponsors & Collaborators

  • Mallinckrodt

    collaborator INDUSTRY

  • Veena Ranganath, MD, MS

    lead OTHER

Principal Investigators

  • Veena K Ranganath, M.D., M.S. · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-20
Primary Completion
2025-05-06
Completion
2025-05-20
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02541955 on ClinicalTrials.gov